The Infectious Diseases Clinical Research Consortium (IDCRC) and Vaccine and Treatment Evaluation Units (VTEUs) work in tandem with the National Institute of Allergy and Infectious Diseases (NIAID) as a coordinated national and global network of scientific experts working to develop and test vaccines and other therapies to combat infectious diseases.


The IDCRC works through a flexible, sustaining structure to advance new countermeasures and approaches to product development, implement efficient clinical study/trial designs, and support exceptional career development and mentoring of future leaders in infectious diseases clinical research. The consortium's collective experience and access to diverse populations give it the ability to evaluate new vaccines and therapies for infectious diseases.

IDCRC Active & Completed Studies

Spotlight: 2023 IDCRC Annual Meeting

From April 24 to 26, the Infectious Diseases Clinical Research Consortium (IDCRC) hosted its Annual Meeting in Bethesda, Maryland at the NIH Main Campus, bringing together 280 stakeholders from the IDCRC, Vaccine and Treatment Evaluation Units (VTEU), and NIAID’s Division of Microbiology and Infectious Diseases (DMID) partners in person and virtually. This year's program highlighted the numerous scientific accomplishments of the IDCRC and VTEUs and provided ample networking opportunities for members.

Read More
IDCRC annual meeting group photo

COVID-19 Prevention Network

The CoVPN was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network; the HIV Prevention Trials Network; the Infectious Diseases Clinical Research Consortium; and the AIDS Clinical Trials Group.

More about the CoVPN
COVID-19 Prevention Network launches two research studies evaluating monoclonal antibodies

IDCRC Sites Across the Nation

IDCRC Leadership Group

Emory University School of Medicine

University of Maryland Baltimore

Baylor College of Medicine

Cincinnati Children’s Hospital Medical Center

FHI 360

Fred Hutch

University of Alabama School of Medicine

Johns Hopkins School of Medicine

Vanderbilt University Medical Center

University of Washington

IDCRC Vaccine & Treatment Evaluation Units (VTEUs)

IDCRC Concept Quick Stats

ICP Status

  • Approved: 48
  • Administratively Not Supported: 23
  • Revise & Resubmit: 5
  • Withdrawn: 12
  • Liaisons: 0
  • EWGs: 1
  • Not Approved: 43
  • EMT: 2
  • Other: 8

EWG Assignment

  • COVID: 87
  • Respiratory: 15
  • STI: 12
  • Malaria/Topical Diseases: 9
  • Enteric Infections: 6
  • Emerging Infections: 7
  • Mpox: 6


  • Prioritization/Protocol Development: 12
  • IDCRC Concept Study Underway: 4
  • Moved forward through other processes: 4
  • Pending: 4
  • Not approved: 9
  • In Process: 6
  • Hold: 5
  • Withdrawn/Halted: 7
  • Note: Protocols Transitioned to IDCRC for Protocol Implementation: 5
  • Other studies in process not from IDCRC concepts (MOMI-VAX, Moderna Pediatric, Moderna Variant, Moderna Boost): 5

IDCRC Citation Statement

Please include the following citation in any publications resulting from direct or indirect IDCRC support:

"Supported by the Infectious Diseases Clinical Research Consortium through the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, under award number UM1AI148684. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."